EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effects of Ambroxol on Aβ and α-Synuclein-Induced Neurotoxicity Through Glucocerebrosidase Activation in HT-22 Hippocampal Neuronal Cells

Sheng-Chieh Lin, Ching-Chi Chang, Sing-Hua Tsou iD, Pai-Yi Chiu iD, Ju-Fang Cheng, Hui-Chih Hung iD, Wei-Jen Chen iD, Ying-Jui Ho, Chih-Li Lin iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sheng-Chieh Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. Hauptthemen laut MEDLINE: Glucosylceramidase, alpha-Synuclein, Ambroxol, Neurons. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital, National Science and Technology Council, National Chung Hsing University and Chung Shan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dementia with Lewy bodies (DLB) is a progressive neurodegenerative disorder marked by the accumulation of α-synuclein (αSyn), often co-existing with amyloid β (Aβ) pathology. Current treatments are largely symptomatic, highlighting a critical need for disease-modifying therapies. Evidence suggests that αSyn aggregates contribute to neuronal death in DLB, particularly when exacerbated by Aβ. Given the role of autophagy in clearing misfolded proteins, exploring agents that promote this pathway is essential for developing effective treatments. Ambroxol (AMBX), a mucolytic drug, has demonstrated potential in activating glucocerebrosidase (GCase), an enzyme that enhances lysosomal function and facilitates the autophagic clearance of toxic protein aggregates, including αSyn. This study aims to evaluate AMBX’s neuroprotective effects in a cellular model of DLB, with the goal of identifying new therapeutic agents that target the underlying pathology of DLB. In this study, HT-22 hippocampal neuronal cells were exposed to αSyn and Aβ, followed by AMBX treatment. Our results showed that AMBX significantly improved cell viability and reduced apoptosis in cells co-treated with αSyn and Aβ. Additionally, AMBX restored GCase activity, promoted autophagy, and reduced oxidative stress, which in turn mitigated αSyn aggregation and phosphorylation. These findings suggest that by activating GCase and enhancing autophagy, AMBX may help alleviate DLB-associated neurodegeneration. This study underscores the potential of AMBX as a therapeutic agent for DLB and supports further investigation in animal models and clinical trials to validate its efficacy in neurodegenerative disease contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucosylceramidasealpha-SynucleinAmbroxolNeuronsAmyloid beta-PeptidesHippocampusNeuroprotective AgentsAutophagyAnimalsMiceCell LineOxidative StressApoptosisCell SurvivalHumansLewy Body Disease

Stichwörter der Autor:innen

Ambroxol (AMBX)amyloid β (Aβ)autophagyglucocerebrosidaseαSyn (αSyn)

Substanzen

Glucosylceramidasealpha-SynucleinAmbroxolAmyloid beta-PeptidesNeuroprotective Agents

Autor:innen und Institutionen

  • School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Department of Orthopedics, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Psychiatry, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Neurology, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
  • Division of Pediatric Neurology, Changhua Christian Hospital, Changhua 500, Taiwan.

ORCID-Profile: Sing-Hua Tsou, Pai-Yi Chiu, Hui-Chih Hung, Wei-Jen Chen, Chih-Li Lin

Förderung

  • Chung Shan Medical University Hospital
  • National Science and Technology Council
  • National Chung Hsing University and Chung Shan Medical University
  • National Science and Technology Council of Taiwan

Zitieren

APA

Lin, S. C., Chang, C. C., Tsou, S. H., Chiu, P. Y., Cheng, J. F., Hung, H. C., Chen, W. J., Ho, Y. J., & Lin, C. L. (2024). Protective Effects of Ambroxol on Aβ and α-Synuclein-Induced Neurotoxicity Through Glucocerebrosidase Activation in HT-22 Hippocampal Neuronal Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212114

Vancouver

Lin SC, Chang CC, Tsou SH, Chiu PY, Cheng JF, Hung HC, et al. Protective Effects of Ambroxol on Aβ and α-Synuclein-Induced Neurotoxicity Through Glucocerebrosidase Activation in HT-22 Hippocampal Neuronal Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212114

BibTeX
@article{Lin2024,
  author = {Lin, Sheng-Chieh and Chang, Ching-Chi and Tsou, Sing-Hua and Chiu, Pai-Yi and Cheng, Ju-Fang and Hung, Hui-Chih and Chen, Wei-Jen and Ho, Ying-Jui and Lin, Chih-Li},
  title = {Protective Effects of Ambroxol on Aβ and α-Synuclein-Induced Neurotoxicity Through Glucocerebrosidase Activation in HT-22 Hippocampal Neuronal Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212114}
}
Kostenlos starten →